Unknown

Dataset Information

0

Molecular-targeted first-line therapy for advanced gastric cancer.

ABSTRACT:

SUBMITTER: Song H 

PROVIDER: S-EPMC6457914 | biostudies-literature |

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown First-line systemic therapy for advanced gastric cancer: a systematic review and network meta-analysis.
| S-EPMC6767753 | biostudies-literature
Unknown Targeted and novel therapy in advanced gastric cancer.
| S-EPMC6788003 | biostudies-literature
Unknown Current Molecular Targeted Agents for Advanced Gastric Cancer.
| S-EPMC7229784 | biostudies-literature
Unknown The progress of targeted therapy in advanced gastric cancer.
| S-EPMC3878836 | biostudies-literature
Unknown First-line treatment of apatinib in elderly patient of advanced gastric carcinoma: A case report of NGS-driven targeted therapy.
| S-EPMC5915029 | biostudies-literature
Unknown Targeted first-line therapies for advanced colorectal cancer: a Bayesian meta-analysis.
| S-EPMC5630427 | biostudies-literature
Unknown Molecular targeted therapies in advanced gastric cancer: does tumor histology matter?
| S-EPMC3539290 | biostudies-literature
Unknown Targeted therapy in gastric cancer.
| S-EPMC5065582 | biostudies-other
Unknown Niraparib: A Review in First-Line Maintenance Therapy in Advanced Ovarian Cancer.
| S-EPMC8613118 | biostudies-literature
Unknown Anti-claudin 18.2 antibody as new targeted therapy for advanced gastric cancer.
| S-EPMC5427576 | biostudies-literature